TNF and histoplasmosis: Resumption of immunomodulatory therapies including anti-TNF therapy must be undertaken cautiously in patients who developed histoplasmosis while on anti-TNF therapy as there is a risk of serious relapse of the infection despite suppressive antifungal therapy.